Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression.
Nat Cancer. 2023 Jan;4(1):108-127. doi: 10.1038/s43018-022-00486-8. Epub 2022 Dec 29.
Nat Cancer. 2023.
PMID: 36581736
Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms.
He F, Laranjeira AB, Kong T, Lin S, Ashworth KJ, Liu A, Lasky NM, Fisher DA, Cox MJ, Fulbright MC, Antunes-Heck L, Yu L, Brakhane M, Gao B, Sykes SM, D'Alessandro A, Di Paola J, Oh ST.
He F, et al. Among authors: fulbright mc.
J Clin Invest. 2024 Feb 1;134(3):e172256. doi: 10.1172/JCI172256.
J Clin Invest. 2024.
PMID: 38060311
Free PMC article.
Item in Clipboard
In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms.
Laranjeira ABA, Kong T, Snyder SC, Fulbright MC, Fisher DAC, Starczynowski DT, Oh ST.
Laranjeira ABA, et al. Among authors: fulbright mc.
Blood. 2024 Mar 8:blood.2023022804. doi: 10.1182/blood.2023022804. Online ahead of print.
Blood. 2024.
PMID: 38457657
Item in Clipboard
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition.
Kong T, Laranjeira ABA, Collins TB, De Togni ES, Wong AJ, Fulbright MC, Ruzinova M, Celik H, Challen GA, Fisher DAC, Oh ST.
Kong T, et al. Among authors: fulbright mc.
Blood Adv. 2022 Jan 25;6(2):611-623. doi: 10.1182/bloodadvances.2020002804.
Blood Adv. 2022.
PMID: 34644371
Free PMC article.
Item in Clipboard
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice.
Fisher DAC, Laranjeira ABA, Kong T, Snyder SC, Shim K, Fulbright MC, Oh ST.
Fisher DAC, et al. Among authors: fulbright mc.
Exp Hematol. 2023 Dec;128:48-66. doi: 10.1016/j.exphem.2023.08.005. Epub 2023 Aug 21.
Exp Hematol. 2023.
PMID: 37611729
Item in Clipboard
Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms.
Collins TB, Laranjeira ABA, Kong T, Fulbright MC, Fisher DAC, Sturgeon CM, Batista LFZ, Oh ST.
Collins TB, et al. Among authors: fulbright mc.
Exp Hematol. 2024 Apr;132:104178. doi: 10.1016/j.exphem.2024.104178. Epub 2024 Feb 9.
Exp Hematol. 2024.
PMID: 38340948
Item in Clipboard
Cite
Cite